Advertisement
  • Forward Look

    Guiding Patients From Screening Through Treatment

    Patient navigators can play an important role in cancer care.

    by Alanna Kennedy-Gorman

  • Forward Look

    Vitamin E and Cancer Risk

    Studies send mixed signals on potential benefits and harmful effects of vitamin E.

    by Mitzi Baker

  • Cutting Cancer’s Engine

    Renewed interest in research about metabolism, the process cells use to fuel their growth, could lead to new types of cancer treatments.

    by Stephen Ornes

  • Missing the Mark

    Only one-third of new cancer therapies or drug combinations tested in phase III clinical trials prove to be better than the standard of care. Researchers explain why and how they are aiming to improve the odds.

    by Sue Rochman

  • Forward Look

    Bridging the Distance

    Q&A with medical oncologist Ana María López, medical director of the telemedicine program at the University of Arizona Cancer Center in Tucson.

    by Sue Rochman

  • Forward Look

    Treading Carefully With Medical Scans

    To reduce your long-term cancer risk, make sure the tests are justified.

    by Ingfei Chen

  • Forward Look

    A Trojan Horse to Fight Cancer

    An experimental treatment shows the potential of a new family of targeted drugs.

    by Stephen Ornes

  • Forward Look

    Common-Sense Screening

    Sigmoidoscopy may be a good option for colorectal cancer screening.

    by Sue Rochman

  • Forward Look

    Task Force Says “No” to PSA for Prostate Cancer Screening

    Expert panel's recommendation spurs debate.

    by Stephen Ornes

  • A Genetic Legacy

    Doctors now know more than ever about the inherited cancer-related mutations that can link generations of family members. But with the new knowledge from scientific advances and DNA testing come new questions for patients.

    by Sue Rochman